Daniel Fleck

Daniel Fleck is an accomplished scientist with extensive experience in biomarker research. Currently serving as a Biomarker Senior Scientist at Denali Therapeutics since June 2019, Daniel previously held the position of Biomarker Scientist at the same company. Prior to this role, Daniel worked at Genentech from May 2014 to May 2019 as a Postdoctoral Research Fellow. Daniel's academic foundation includes a PhD from Ludwig-Maximilians-University of Munich, where research was conducted from June 2009 to April 2014 as a PhD student.